Cancer diagnostics News and Research

RSS

Study shows miRNAs in semen as non-invasive biomarkers for prostate cancer

Researchers of the Human Molecular Genetics group at the Bellvitge Biomedical Research Institute, led by Dr. Sara Larriba, in collaboration with Dr. Francesc Vigués and Dr. Manel Castells of the Urology Service of Bellvitge University Hospital, show the usefulness of certain molecules, the miRNAs in semen, as non-invasive biomarkers for prostate cancer.

26 Sep 2019

Targeting cancer patients' mindsets could improve their health and well-being

A diagnosis of cancer can cause significant emotional burden for patients and their families. The turmoil may persist throughout treatment and even years into survivorship.

25 Sep 2019

New genetic test could help avoid unnecessary prostate cancer surgery

Men who develop prostate cancer could avoid having unnecessary surgery or radiotherapy thanks to a new, more precise genetic test which is being trialed in Leeds.

25 Sep 2019

Global survey highlights unmet need of women living with cancer

Merck, a leading science and technology company, today released the Supporting Women With Cancer report, presenting findings from a global survey of 4,585 women across 23 countries.

25 Sep 2019

Early palliative care linked to better survival in patients with advanced lung cancer

Early palliative care is associated with better survival in patients with advanced lung cancer, according to a study by VA Portland Health Care System and Oregon Health and Science University researchers.

19 Sep 2019

Cancer patients who miss an appointment more likely to die within 12 months of diagnosis

Cancer patients who miss an urgent referral appointment for their symptoms are 12% more likely to die within 12 months of diagnosis, a major new study has found.

12 Sep 2019

Novel technology makes biopsies less invasive and more informative

A team of researchers from the National University of Singapore has developed a novel technology that could sensitively and accurately detect and classify cancer cells, as well as determine the disease aggressiveness from the least invasive biopsies.

10 Sep 2019

Liquid biopsies provide complete picture of genetic alterations linked to cancer drug resistance

Many patients see their tumors shrink in response to a drug, only to have them come back with a vengeance as they evolve to fend off the treatment. Oncologists want to be able to quickly detect cancer drug resistance as it emerges in their patients and identify another drug the tumors will still respond to.

10 Sep 2019

New blood test could aid earlier and precise diagnosis of lung cancer

Lung cancer can be spotted earlier and diagnosed more precisely with the help of a blood test, a major study carried out in Scotland has found.

9 Sep 2019

Researchers develop new cocktail of drugs that shrink pancreatic tumors

Cancer is relentless and resilient. When a drug blocks a cancer cell's main survival pathway, the cell avoids the obstacle by taking different pathways or detours to save itself. This tactic is called "developing resistance," and it's one of the key challenges researchers face when seeking effective therapeutics to combat pancreatic ductal adenocarcinoma (PDA).

9 Sep 2019

IASLC highlights importance of tobacco cessation after cancer diagnosis

The International Association for the Study of Lung Cancer today used the platform of its largest international meeting to call attention to the importance of tobacco cessation after cancer diagnosis, and urged all physicians to screen cancer patients for tobacco use and recommend tobacco cessation.

8 Sep 2019

MicroRNA methylation may be useful biomarker for early cancer diagnosis

Levels of molecules associated with genetic function, such as microRNA, can be an important indicator of abnormal activity associated with cancer. However, little is known about how different molecules are altered in cancerous cells.

4 Sep 2019

Researchers receive $2.9 million to develop new low-cost cancer diagnostic platform

Researchers at the University of Notre Dame have received $2.9 million to develop a new diagnostic platform that could diagnose cancer in as little as three hours by using only one or two drops of blood.

28 Aug 2019

Cancer survivors could be at greater risk of cardiovascular diseases

Over the last few decades, medical progress has led to the survival of many more people with cancer. However, a new study published in The Lancet shows that this cohort has a higher risk of cardiovascular disease (CVD) than controls without cancer, due to a number of reasons.

21 Aug 2019

DNA methylation may influence the effects of aspirin in patients with breast cancer

Women with a particular DNA feature may live longer if they take aspirin even before they are diagnosed with breast cancer, a new study found.

13 Aug 2019

New test may improve the ability to diagnose riskiest forms of HPV infection

Ninety-nine percent of cervical cancers are caused by human papillomavirus (HPV). More than 200 HPVs, some of which are associated with varying degrees of cancer risk, complicate diagnosis and treatment.

12 Aug 2019

AI system could help better detect and diagnose breast cancer

UCLA researchers have developed an artificial intelligence system that could help pathologists read biopsies more accurately and to better detect and diagnose breast cancer.

12 Aug 2019

Antiviral drugs for hepatitis C reduce liver-related deaths by nearly half, study shows

A new study from the UT Southwestern Simmons Comprehensive Cancer Center demonstrates that antiviral drugs for hepatitis C reduce liver-related deaths by nearly 50% in patients with a history of liver cancer.

10 Aug 2019

Strong free-electron lasers can be used to break down amyloid protein aggregates

Amyloid fibrils are a type of self-assembled proteins/peptides that take on a stacked sheet-like formation. Amyloid fibril aggregates are known to be a cause of several diseases--including Alzheimer's--and therefore, it is of immense scientific interest to understand how these aggregates can be broken.

8 Aug 2019

New Milford Hospital’s Eating Well program offers comfort to patients and caregivers

Diane and Phil Hannah started their lifelong journey together as neighbors who would talk to each other from their bedroom windows. They were high school sweethearts before they married in 1952.

8 Aug 2019

Cancer diagnostics News and Research

Study shows miRNAs in semen as non-invasive biomarkers for prostate cancer

Targeting cancer patients' mindsets could improve their health and well-being

New genetic test could help avoid unnecessary prostate cancer surgery

Global survey highlights unmet need of women living with cancer

Early palliative care linked to better survival in patients with advanced lung cancer

Cancer patients who miss an appointment more likely to die within 12 months of diagnosis

Novel technology makes biopsies less invasive and more informative

Liquid biopsies provide complete picture of genetic alterations linked to cancer drug resistance

New blood test could aid earlier and precise diagnosis of lung cancer

Researchers develop new cocktail of drugs that shrink pancreatic tumors

IASLC highlights importance of tobacco cessation after cancer diagnosis

MicroRNA methylation may be useful biomarker for early cancer diagnosis

Researchers receive $2.9 million to develop new low-cost cancer diagnostic platform

Cancer survivors could be at greater risk of cardiovascular diseases

DNA methylation may influence the effects of aspirin in patients with breast cancer

New test may improve the ability to diagnose riskiest forms of HPV infection

AI system could help better detect and diagnose breast cancer

Antiviral drugs for hepatitis C reduce liver-related deaths by nearly half, study shows

Strong free-electron lasers can be used to break down amyloid protein aggregates

New Milford Hospital’s Eating Well program offers comfort to patients and caregivers

Cancer Research - Second Edition eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News